Soichiro Ando
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in ⓘ
- Co-authors
- Tomohiko Iida (9 shared papers)Hideki Kimura (6 shared papers)Takahiro Nakajima (6 shared papers)Thomas J. Santoro (2 shared papers)Rodney C. Baker (1 shared paper)Makoto Suzuki (4 shared papers)Makoto Suzuki (3 shared papers)Naomichi Iwai (4 shared papers)
- Journals
- Oncology Reports (4 papers)Lung Cancer (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)Lipids in Health and Disease (1 paper)BMC Cancer (1 paper)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Soichiro Ando
26 papers receiving 387 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 57
- Pulmonary and Respiratory Medicine 102
- Oncology 76
- Microbiology 2
- Molecular Biology 150
Countries citing papers authored by Soichiro Ando
This map shows the geographic impact of Soichiro Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Ando more than expected).
Fields of papers citing papers by Soichiro Ando
This network shows the impact of papers produced by Soichiro Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Ando. The network helps show where Soichiro Ando may publish in the future.
Co-authors
The 25 scholars most cited alongside Soichiro Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 57 | |
| 2 | 2005 | 43 | |
| 3 | The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer. | 2004 | 39 |
| 4 | 2006 | 39 | |
| 5 | 1998 | 30 | |
| 6 | 2006 | 30 | |
| 7 | Positive reactions for both Cyfra21-1 and CA125 indicate worst prognosis in non-small cell lung cancer. | 2003 | 26 |
| 8 | 2005 | 22 | |
| 9 | 2003 | 21 | |
| 10 | 2006 | 16 | |
| 11 | 2003 | 13 | |
| 12 | 2018 | 10 | |
| 13 | 2007 | 9 | |
| 14 | 2000 | 8 | |
| 15 | 2019 | 7 | |
| 16 | 2005 | 6 | |
| 17 | VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxel. | 2009 | 6 |
| 18 | 2005 | 4 | |
| 19 | 1993 | 3 | |
| 20 | 1998 | 3 |
About Soichiro Ando
Soichiro Ando is a scholar working on Microbiology, Rheumatology, Hepatology, Pulmonary and Respiratory Medicine and Ophthalmology, having authored 26 papers that have together received 399 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), Pleural and Pulmonary Diseases (3 papers), Influenza Virus Research Studies (3 papers), Lung Cancer Research Studies (3 papers), Myasthenia Gravis and Thymoma (3 papers), Respiratory viral infections research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Medical Imaging and Pathology Studies (2 papers). The work is most often cited by research in Cancer Research (57 citations), Pulmonary and Respiratory Medicine (102 citations), Oncology (76 citations), Microbiology (2 citations) and Molecular Biology (150 citations). Soichiro Ando has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Tomohiko Iida, Hideki Kimura, Hideki Kimura, Takahiro Nakajima, Thomas J. Santoro, Rodney C. Baker, Makoto Suzuki, Makoto Suzuki, Naomichi Iwai and Naoyoshi Yamamoto. Their work appears in journals such as Oncology Reports, Lung Cancer, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Lipids in Health and Disease and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.